Carfilzomib for Treatment of Chronic Graft vs. Host Disease
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2017
At a glance
- Drugs Carfilzomib (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions; Therapeutic Use
- 05 Dec 2017 Planned primary completion date changed from 1 Jun 2018 to 12 Jun 2018.
- 05 Dec 2017 Status changed from recruiting to active, no longer recruiting.
- 07 Jan 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.